METHOD AND SYSTEM FOR SPECTRAL DATA ANALYSIS
Characteristics of proteins, peptides, and/or CIpeptoids can be determined via two-dimensional correlation spectroscopy and/or two-dimensional co-distribution spectroscopies. Spectral data of the proteins, peptides, and/or peptoids can be obtained with respect to an applied perturbation, two-dimensional co-distribution analysis can be applied to generate an asynchronous co-distribution plot for the proteins, peptides, and/or peptoids to define the population of proteins in solution. In the two-dimensional asynchronous plot, a cross peak can be identified as correlating with an auto peak in the two-dimensional correlation synchronous plot associated with aggregation of the proteins, peptides, and/or peptoids. The two-dimensional asynchronous cross peak can be used to determine an order of a distributed presence of spectral intensities with respect to the applied perturbation. For example, for two wavenumbers v 1 and v 2 , the value of the cross peak corresponding to the two wavenumbers can indicate a presence of spectral intensity at v 1 relative to the presence of spectral intensity at v 2 .
1 . A method for processing data representing a characteristic of proteins, peptides, and/or peptoids, the method comprising:
obtaining spectral data of the proteins, peptides, and/or peptoids with respect to an applied perturbation;
applying two-dimensional co-distribution (2DCDS) analysis to generate an asynchronous co-distribution plot for the proteins, peptides, and/or peptoids;
identifying in the asynchronous co-distribution plot a cross peak that correlates with an auto peak associated with aggregation of the proteins, peptides, and/or peptoids; and
using the cross peak to determine an order of a distributed presence of spectral intensities with respect to the applied perturbation.
2 . The method of claim 1 , wherein using the cross peak comprises:
determining, for two wavenumbers v 1 and v 2 , whether the cross peak corresponding to the two wavenumbers has a positive value; and
when the cross peak has a positive value, determining that a presence of spectral intensity at v 1 is distributed within an interval of the applied perturbation that is lower than an interval within which a presence of spectral intensity at v 2 is distributed.
3 . The method of claim 1 , wherein using the cross peak comprises:
determining, for two wavenumbers v 1 and v 2 , whether the cross peak corresponding to the two wavenumbers has a negative value; and
when the cross peak has a negative value, determining that a presence of spectral intensity at v 2 is distributed within an interval of the applied perturbation that is lower than an interval within which a presence of spectral intensity at v 1 is distributed.
4 . (canceled)
5 . The method of claim 1 , wherein an asynchronous co-distribution intensity in the asynchronous co-distribution plot is represented as a difference in distributions of two spectral signals.
6 . The method of claim 1 , wherein the applied perturbation is time, temperature, concentration, or pressure.
7 . The method of claim 1 , further comprising:
applying the two-dimensional co-distribution (2DCDS) analysis to generate a synchronous co-distribution plot for the proteins, peptides, and/or peptoids;
identifying, in the synchronous co-distribution plot, synchronous co-distribution peaks associated with aggregation of the proteins, peptides, and/or peptoids; and
using the synchronous co-distribution peaks to determine a degree of overlap of distribution patterns for spectral intensities with respect to the applied perturbation.
8 . The method of claim 1 , wherein using the synchronous co-distribution peaks comprises: determining, for two wavenumbers v 1 and v 2 , whether the synchronous co-distribution peaks corresponding to the two wavenumbers are within a range.
9 . The method of claim 1 , further comprising:
applying two-dimensional correlation (2DCOS) analysis, generating a synchronous correlation plot and an asynchronous correlation plot for the proteins, peptides, and/or peptoids;
identifying, in the synchronous correlation plot, positive cross peaks that correlate with auto peaks associated with aggregation of the proteins, peptides, and/or peptoids; and
using identified peak intensities of the spectral data to determine an amount of aggregation of the proteins, peptides, and/or peptoids.
10 . The method of claim 9 , further comprising comparing the amount of aggregation of the proteins, peptides, and/or peptoids to an order of a distributed presence of spectral intensities with respect to the applied perturbation.
11 . (canceled)
12 . (canceled)
13 . The method of claim 1 , further comprising determining a size and a number of particulates to ascertain population distribution of the particulates.
14 . The method of claim 1 , further comprising analyzing the spectral data to verify signal-to-noise ratio, perform a baseline correction, determine water vapor content, and/or determine signal intensity within a spectral region.
15 . The method of claim 1 , further comprising generating covariance or dynamic spectral data based on perturbation of a sample.
16 . The method of claim 1 , further comprising correlating changes, comprising peak intensities, in the spectral data that are in-phase with one another as obtained in the synchronous plot.
17 . (canceled)
18 . (canceled)
19 . (canceled)
20 . The method of claim 1 , further comprising determining a minimum number of underlying spectral contributions in a band, performing curve fitting analysis, and determining a secondary structure composition of a sample.
21 . (canceled)
22 . The method of claim 1 , further comprising correlating changes, comprising peak intensities, in the spectral data that are out-of-phase from one another as obtained in the asynchronous plot.
23 . The method of claim 1 , further comprising determining the presence and/or extent of deamination of amino acid side chains in the proteins, peptides, and/or peptoids.
24 . The method of claim 1 , further comprising determining the stability of domains in the proteins, peptides, and/or peptoids.
25 . A system for processing data representing a characteristic of proteins. peptides, and/or peptoids, the system comprising:
a data acquisition module configured to obtain spectral data of the proteins. peptides, and/or peptoids with respect to an applied perturbation; and
a correlation analysis module configured to:
apply two-dimensional co-distribution (2DCDS) analysis to generate an asynchronous co-distribution plot for the proteins, peptides, and/or peptoids;
identify in the asynchronous co-distribution plot a cross peak that correlates with an auto peak associated with aggregation of the proteins, peptides, and/or peptoids; and
use the cross peak to determine an order of a distributed presence of spectral intensities with respect to the applied perturbation.
26 . The system of claim 25 , further comprising a visual model generator for generating one or more plots for display.
27 . (canceled)
28 . (canceled)
29 . Non-transitory computer-readable medium comprising instructions which, when executed by one or more computers, cause the one or more computers to:
obtain spectral data of the proteins, peptides, and/or peptoids with respect to an applied perturbation;
apply two-dimensional co-distribution (2DCDS) analysis to generate an asynchronous co-distribution plot for the proteins, peptides, and/or peptoids;
identify in the asynchronous co-distribution plot a cross peak that correlates with an auto peak associated with aggregation of the proteins, peptides, and/or peptoids; and
use the cross peak to determine an order of a distributed presence of spectral intensities with respect to the applied perturbation.